Ann Hynes
Stock Analyst at Mizuho
(2.25)
# 953
Out of 5,335 analysts
273
Total ratings
62.59%
Success rate
16.61%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
UNH UnitedHealth Group | Maintains: Outperform | 600 650 | 317.73 | 104.58% | 17 | Apr 9, 2025 | |
DGX Quest Diagnostics | Maintains: Outperform | 178 189 | 176 | 7.39% | 14 | Apr 9, 2025 | |
MOH Molina Healthcare | Maintains: Outperform | 376 400 | 314.5 | 27.19% | 8 | Apr 9, 2025 | |
MEDP Medpace Hldgs | Maintains: Outperform | 400 355 | 308.38 | 15.12% | 2 | Apr 9, 2025 | |
IQV IQVIA Hldgs | Maintains: Outperform | 242 210 | 151.8 | 38.34% | 11 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 238 200 | 137.76 | 45.18% | 14 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 305 316 | 235.98 | 33.91% | 8 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 10 | 4.76 | 110.08% | 2 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 455 505 | 383.17 | 31.8% | 4 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 175 155 | 144.07 | 7.59% | 2 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 70 76 | 61.51 | 23.56% | 10 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 19 18 | 14.58 | 23.46% | 2 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 48 37 | 26.72 | 38.47% | 10 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 13 15 | 14.46 | 3.73% | 11 | Nov 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 110 120 | 148.33 | -19.1% | 8 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 20 | 23.48 | -14.82% | 1 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 28 | 21.48 | 30.35% | 1 | Aug 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 118 130 | 156.71 | -17.04% | 14 | May 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 93 95 | 117.88 | -19.41% | 8 | Apr 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 370 385 | 304.27 | 26.53% | 10 | Mar 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 175 200 | 192.13 | 4.1% | 15 | Mar 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 242 268 | 2 | 13300% | 1 | Feb 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 450 505 | 687.29 | -26.52% | 17 | Feb 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 257 230 | 251.16 | -8.42% | 15 | Oct 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 325 275 | 365.64 | -24.79% | 19 | Oct 25, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 31 25 | 11.37 | 119.88% | 8 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 48 50 | 23.21 | 115.42% | 2 | Jul 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 80 76 | 59.95 | 26.77% | 7 | Jul 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 174 192 | n/a | n/a | 10 | Jul 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 38 43 | n/a | n/a | 9 | May 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 450 510 | n/a | n/a | 5 | Dec 20, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | n/a | n/a | 1 | Mar 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 82 0 | n/a | n/a | 2 | Jan 24, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 90 0 | n/a | n/a | 2 | Nov 9, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 57 | 1.53 | 3625.49% | 1 | Sep 21, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jul 20, 2017 |